Alloy vs YourEra
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
YourEra
Best for patients comfortable with a $99 first-month entry price who are willing to confirm steady-state ongoing pricing at checkout before committingStarting at $99/mo
Side-by-Side Comparison
| Feature | Alloy | YourEra |
|---|---|---|
| Overall Score | ✓7.4/10 | 7.1/10 |
| Starting Price | ✓$80/mo | $99/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.6 ★ /5 |
| Features | ✓8 features | 5 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
YourEra
Pros
- ✓$99 first-month entry pricing for compounded GLP-1 access is competitive with the cheapest decile of the US compounded telehealth market
- ✓LegitScript Certified seal displayed in the footer (the standard third-party telehealth/pharmacy accreditation)
- ✓100% online doctor visits and prescriptions disclosed clearly
- ✓Site is honest that the compounded medications are NOT the brand-name Ozempic/Wegovy/Mounjaro/Zepbound — material YMYL transparency
Cons
- ✗Steady-state ongoing monthly price NOT publicly disclosed (gated behind checkout) — patients should ask for the maintenance-dose price before committing
- ✗Specific legal entity name + state of incorporation NOT publicly disclosed on the home page — material YMYL transparency gap
- ✗Pharmacy partners NOT publicly named (described generically as 'state-licensed pharmacies')
- ✗Per-state availability NOT enumerated; verify your state ships before purchase
- ✗Initial consultation fee structure NOT disclosed publicly
- ✗Lab work + ongoing-care touchpoints NOT clearly disclosed in marketing copy
Our Verdict
Alloy edges out YourEra with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. YourEra remains a solid alternative, especially if you're looking for patients comfortable with a $99 first-month entry price who are willing to confirm steady-state ongoing pricing at checkout before committing.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.